Best Cardiac and Vascular Disorders Companies in South Korea
The 36 best Cardiac and Vascular Disorders companies in South Korea in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Zymedi.
Ranked: Best Cardiac and Vascular Disorders companies in South Korea
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Zymedi Developer of therapeutics for multiple diseases 29Patents top 31%Moat top 32%Innovation top 40%Funding top 41% All 9 signals ▾Patentstop 31% Moattop 32% Innovationtop 40% Fundingtop 41% Growthtop 45% Talentbottom 49% Globalbottom 35% Marketbottom 25% Techbottom 23% Patents: 31 patents matched (strict assignee match) · 28 filings since 2022 vs 3 in 2017-21 Moat: Editorial + unicorn rating 4/10 · IP moat: 31 patents rank vs industry peers · Fliar Intelligence Index 29/100 | $30M | 39 mo ago | Series A | Nam Kwon CEO | 2019 | WordPressMySQLPHP+15 | 31 patents Lysyl‑tRNA synthetase 1 inhibitors and immune‑modulating peptides for inflammatory disease therapy | — |
| 2 | MEZOO Developer of a wearable ECG monitoring device 48Product top 28%Innovation top 31%Moat top 32%Funding top 36% All 10 signals ▾Producttop 28% Innovationtop 31% Moattop 32% Fundingtop 36% Patentstop 36% Growthtop 45% Talentbottom 49% Marketbottom 43% Techbottom 37% Globalbottom 36% Product: 1 published app (18 installs) · Company stage: Public Innovation: 43 patents (top 51% of patent-holders) · 34 filings since 2022 vs 9 in 2017-21 rank vs industry peers · Fliar Intelligence Index 48/100 | $23M | 34 mo ago | Public | Junghwan Park Founder & CEO | 2014 | PHPGSAPApache HTTP Server+8 | 43 patents ECG lead placement guidance and wearable cardiac/physiological monitoring technologies | — |
| 3 | Wellysis Provider of smart wearable wristband and app for ECG monitoring | $4M | 51 mo ago | Series A | Young Juhn CEO | 2019 | — | 18 patents Patents concentrated in health & consumer products | — |
| 4 | Kalos Medical Developer of medical devices for the treatment of hypertension & other chronic diseases | $4M | 38 mo ago | Funding Raised | Chul Kim CEO | 2015 | — | 35 patents Catheter-based minimally invasive nerve denervation and block devices for medical procedures. | — |
| 5 | Karis Bio Developer of cell therapies for cardiovascular diseases 29Funding top 49%Talent bottom 45%Market bottom 38%Global bottom 36% All 4 signals ▾Fundingtop 49% Talentbottom 45% Marketbottom 38% Globalbottom 36% Funding: Raised $307k across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Talent: 1 named leader on record rank vs industry peers · Fliar Intelligence Index 29/100 | $307K | 12 mo ago | Funding Raised | Young Yoon CEO | 2020 | — | — | — |
| 6 | DC Medical Developer of biomimetic mesh and pre-mature birth diagnostic kit | — | 87 mo ago | Deadpooled | Dave Gabriel CEO | 2018 | — | 527 patents AI-based cardiac diagnostics and health monitoring using ECG and biometric data | — |
| 7 | Mezzion Developer of novel therapeutics addressing unmet needs in global markets | — | 142 mo ago | Public | Donghyun Park CEO | 2002 | GnuboardMySQLPHP+11 | — | — |
| 8 | Nanoomtech Manufactures automatic defibrillator emergency rescue and medical equipment | — | 197 mo ago | Series A | Choi Moo Jin CEO | 2005 | — | 4 patents Automated external defibrillator pad placement guidance and bone‑density measurement systems. | — |
Top 8 Cardiac and Vascular Disorders companies in South Korea
#1
Funding Raised · Seoul, Seoul · founded 2020 · 24 employees$306.6Kraised▾
Developer of cell therapies for cardiovascular diseases. The company has human-induced pluripotent stem cell therapeutics for the treatment of peripheral arterial disease, hemic heart disease, diabetic retinopathy, diabetic neuropathy, and wound healing.
- Aug 2025Grant (prize money)$306.6K
#2
Public · Wonju si, Gangwon Province · founded 2014 · 46 employees$23.5Mraised▾
Developer of a wearable ECG monitoring device. HiCardi is the patch-type ECG device used by medical professionals for the remote monitoring of patients with heart disease or after major heart treatments.
- Nov 2023Series B$13.8M
#3
Series A · Incheon, Incheon · founded 2019$29.5Mraised▾
Developer of therapeutics for multiple diseases. It offers Aminoacyl-tRNA Synthetase-based drugs which include ZM-A001 for Pulmonary arterial hypertension, ZM-C001 for NASH (Non-alcoholic steatohepatitis), and ZM-C101 for colorectal cancer.
- May 2023Series A$12.1M
- 2021Series A$17.5M
#4
Funding Raised · Suwon-si, Gyeonggi-do · founded 2015$3.5Mraised▾
Developer of medical devices for the treatment of hypertension & other chronic diseases. The company uses a proprietary catheter-based technology to develop DENEX, a medical device for the treatment of hypertension for renal denervation.
- Jul 2023Grant (prize money)$3.5M
#5
Series A · Seoul, Seoul · founded 2019 · 30 employees$4Mraised▾
Provider of smart wearable wristband and app for ECG monitoring. The users can verify the live-streaming ECG on their mobile devices. The ECG report is automatically transferred to the cloud platform for AI-assisted analysis and interpretation from the analysis the cardiologists can diagnose heart-related diseases.
- May 2022Series A$4M
#6
Deadpooled · Seoul, Seoul · founded 2018 · 24 employees—raised▾
Developer of medical devices designed to provide better care for people's lives and lifestyles. The company's devices are primarily focused on pelvic organs, hernia surgery, and polypropylene prolapse, enabling medical sectors to save people and improve human dignity with medical devices.
- 2019Seed—
#7
Public · Seoul, Seoul · founded 2002 · 48 employees—raised▾
Developer of novel therapeutics addressing unmet needs in global markets. The company focuses on developing new drug substances with efficacy and safety profiles for various indications. It has capabilities in clinical trial management, regulatory interactions, and identifying potential drug candidates. The company also has experience in licensing and commercialization strategies.
- Nov 2014Post IPO—
#8
Series A · Gwangju, Gwangju · founded 2005 · 75 employees—raised▾
NANOOMTECH manufactures and markets a wide range of of medical and electronic devices. The company's product line includes automated external defibrillator, equipment for children growth analysis, and video camcorders for infrared imaging.
- Apr 2010Series A—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Cardiac and Vascular Disorders coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.